NATURE’S SUNSHINE PRODUCTS, INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $1.99M, a 21.55% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $1.64M, a 26.08% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $1.29M, a 35.37% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $1.64M, a 29.90% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $5.78M, a 20.72% increase from fiscal 2024.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $4.79M, a 2.15% decline from fiscal 2023.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $4.89M, a 68.67% increase from fiscal 2022.
- NATURE’S SUNSHINE PRODUCTS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $2.90M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $1.99M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.64M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $5.78M 10-K · filed 2026-03-10 | |
| 2025-09-30 | $1.29M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.64M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $1.30M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $4.79M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $950.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.26M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $1.37M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $4.89M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $1.29M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.44M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $1.06M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $2.90M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $593.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $540.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $801.00K 10-Q · filed 2023-11-07 | |
| 2021-09-30 | $886.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $1.07M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $1.00M 10-Q · filed 2022-11-03 | |
| 2020-09-30 | $1.01M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $736.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $394.00K 10-Q · filed 2021-11-04 | |
| 2019-09-30 | $678.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $621.00K 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $230.00K 10-Q · filed 2020-11-09 | |
| 2018-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2018-06-30 | $581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | |
| 2018-03-31 | $543.00K 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$508.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | $984.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $176.00K derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | $778.00K 10-Q · filed 2017-05-10 | -$104.00K derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 10-K · filed 2017-03-14 |
| 2016-09-30 | $826.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.00M derived: sum of 4 quarters · filed 2017-03-14 |
| 2016-06-30 | $704.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.36M derived: sum of 4 quarters · filed 2017-03-14 |
| 2016-03-31 | $882.00K 10-Q · filed 2016-05-10 | $3.40M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-12-31 | $585.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $3.86M 10-K · filed 2017-03-14 |
| 2015-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.01M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $746.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $1.34M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $772.00K 10-K · filed 2017-03-14 |
| 2013-12-31 | $3.39M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $2.88M 10-K · filed 2015-03-13 | |
| 2011-12-31 | $3.48M 10-K · filed 2014-03-17 | |
| 2010-12-31 | $437.00K 10-K · filed 2013-03-07 | |
| 2009-12-31 | $478.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |